Market Cap 55.70M
Revenue (ttm) 16.89M
Net Income (ttm) -37.80M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -223.80%
Debt to Equity Ratio 0.00
Volume 110,100
Avg Vol 148,214
Day's Range N/A - N/A
Shares Out 14.66M
Stochastic %K 13%
Beta -0.75
Analysts Strong Sell
Price Target $16.33

Company Profile

Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company's development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to preven...

Industry: Biotechnology
Sector: Healthcare
Phone: 305 509 6897
Address:
2916 North Miami Avenue, Suite 1000, Miami, United States
mrkymrk
mrkymrk Oct. 25 at 1:44 PM
$VERU well we will know something by the second week of Nov which is when VERU typically reports earnings. (Or lack therof) If Steiner carries the same message this thing will crater to the ground.
0 · Reply
StockGoing
StockGoing Oct. 24 at 2:21 PM
$VIVK $CERO $ASST $VERU 🔥🔥🔥
0 · Reply
Ljkjr
Ljkjr Oct. 23 at 10:37 PM
$VERU Corrected post: It is likely VERU is being shorted by posters on in this blog. You can’t trust anyone on chat boards because for one reason strategies change relative to a stock’s performance and a poster’s portfolio. Big Pharm could be teaming against us too. But I am still optimistic about the data; and some kind of deal being made soon. I have been wrong before. I’ll ride it out—maybe into the sunset.
0 · Reply
Ljkjr
Ljkjr Oct. 23 at 8:58 PM
$VERU It has likely been a short attack. You can’t trust anyone one chat boards. Big Pharm could be teaming against us too. But I am still optimistic that about the data and some kind of deal being made soon. I have been wrong before. I’ll ride it out—maybe into the sunset.
1 · Reply
mrkymrk
mrkymrk Oct. 23 at 7:38 PM
$VERU total clown show
0 · Reply
HoHoHoHum
HoHoHoHum Oct. 23 at 7:17 PM
$VERU is this going to ever come back? Or is this another case of slipping into the BK territory? I would be sad to see the latter happen but so many bios have disappeared into oblivion in the last 3 years.
0 · Reply
Eesnimi
Eesnimi Oct. 23 at 4:16 PM
$VERU All time low coming. Why not
0 · Reply
PennyConnection1
PennyConnection1 Oct. 23 at 2:55 PM
$VERU ladies and germs
0 · Reply
BioRich
BioRich Oct. 23 at 2:57 AM
$ALT $VERU I love it when my biggest stalker tries to bash me and my picks, only to fall on their face... yet again. Thanks @Turribull for trying to get cute with $VERU. Great company with near ZERO lean mass when added to Wegovy. $VERU is another $ALT killer. In a turn of beautiful fortune, $VERU proceeded to gain 4.7% from the time of your ill-advised bash attempt. Oh, and $ALT went down 2.5%. So that means your EE is 8.2% on your embarrassing post. *EE - Effective Embarrassment For those looking to make money and not just join bagholding misery cults... Follow/ Subscribe for more suggestions and perspective. Would love to hear yours. Let's make some money. Cheers!
1 · Reply
cray1965
cray1965 Oct. 22 at 9:40 PM
$VERU I get it — Veru’s history is ugly, no argument there. They’ve pivoted more than once and burned a lot of trust along the way. But calling it a scam is a bit much. And I don't work for Veru, and could just as easily call you a short seller. Enobosarm is real science with peer-reviewed data showing it builds muscle and improves function. The FDA literally gave them the green light for the next trial design (72 weeks, tirzepatide combo), and they just added Dr. Stefan Anker — one of the biggest names in muscle preservation — to the advisory board. That’s not what scam companies do. Yeah, management has made mistakes, but I’m buying the drug, not the drama. The molecule works — and if it does in the next trial what it’s already shown before, any big pharma would want it. That’s where the real value is. Believe what you want, but facts > feelings.
1 · Reply
Latest News on VERU
Veru Inc. (VERU) Q3 2025 Earnings Call Transcript

Aug 12, 2025, 12:57 PM EDT - 2 months ago

Veru Inc. (VERU) Q3 2025 Earnings Call Transcript


Veru Announces Reverse Stock Split

Aug 6, 2025, 8:30 AM EDT - 2 months ago

Veru Announces Reverse Stock Split


Veru to Participate in the 2025 BTIG Virtual Biotech Conference

Jul 22, 2025, 8:30 AM EDT - 3 months ago

Veru to Participate in the 2025 BTIG Virtual Biotech Conference


Veru to Participate in the Virtual BTIG Obesity Health Forum

Jun 11, 2025, 8:30 AM EDT - 4 months ago

Veru to Participate in the Virtual BTIG Obesity Health Forum


Veru's Enobosarm Shows Muscle In Wegovy Combo Trial

May 28, 2025, 12:11 PM EDT - 5 months ago

Veru's Enobosarm Shows Muscle In Wegovy Combo Trial


Veru: Saving Muscle Mass Amidst The GLP-1 Drug Boom

May 26, 2025, 9:36 PM EDT - 5 months ago

Veru: Saving Muscle Mass Amidst The GLP-1 Drug Boom


Veru Inc. (VERU) Q2 2025 Earnings Call Transcript

May 8, 2025, 12:42 PM EDT - 6 months ago

Veru Inc. (VERU) Q2 2025 Earnings Call Transcript


Veru Participates in a Virtual Investor KOL Connect Segment

May 8, 2025, 9:25 AM EDT - 6 months ago

Veru Participates in a Virtual Investor KOL Connect Segment


Veru Inc (VERU) Q1 2025 Earnings Call Transcript

Feb 13, 2025, 2:35 PM EST - 9 months ago

Veru Inc (VERU) Q1 2025 Earnings Call Transcript


Veru Inc. (VERU) Q3 2024 Earnings Call Transcript

Aug 10, 2024, 8:39 AM EDT - 1 year ago

Veru Inc. (VERU) Q3 2024 Earnings Call Transcript


Veru to Present at the Jefferies Global Healthcare Conference

May 22, 2024, 8:30 AM EDT - 1 year ago

Veru to Present at the Jefferies Global Healthcare Conference


Veru Announces Steven B. Heymsfield M.D.

May 15, 2024, 8:30 AM EDT - 1 year ago

Veru Announces Steven B. Heymsfield M.D.


Veru to Present at the GLP-1 Based Therapeutics Summit

May 2, 2024, 8:30 AM EDT - 1 year ago

Veru to Present at the GLP-1 Based Therapeutics Summit


Veru Reschedules Annual Meeting of Shareholders

Mar 22, 2024, 4:05 PM EDT - 1 year ago

Veru Reschedules Annual Meeting of Shareholders


Veru Inc. (VERU) Q1 2024 Earnings Call Transcript

Feb 8, 2024, 1:36 PM EST - 1 year ago

Veru Inc. (VERU) Q1 2024 Earnings Call Transcript


mrkymrk
mrkymrk Oct. 25 at 1:44 PM
$VERU well we will know something by the second week of Nov which is when VERU typically reports earnings. (Or lack therof) If Steiner carries the same message this thing will crater to the ground.
0 · Reply
StockGoing
StockGoing Oct. 24 at 2:21 PM
$VIVK $CERO $ASST $VERU 🔥🔥🔥
0 · Reply
Ljkjr
Ljkjr Oct. 23 at 10:37 PM
$VERU Corrected post: It is likely VERU is being shorted by posters on in this blog. You can’t trust anyone on chat boards because for one reason strategies change relative to a stock’s performance and a poster’s portfolio. Big Pharm could be teaming against us too. But I am still optimistic about the data; and some kind of deal being made soon. I have been wrong before. I’ll ride it out—maybe into the sunset.
0 · Reply
Ljkjr
Ljkjr Oct. 23 at 8:58 PM
$VERU It has likely been a short attack. You can’t trust anyone one chat boards. Big Pharm could be teaming against us too. But I am still optimistic that about the data and some kind of deal being made soon. I have been wrong before. I’ll ride it out—maybe into the sunset.
1 · Reply
mrkymrk
mrkymrk Oct. 23 at 7:38 PM
$VERU total clown show
0 · Reply
HoHoHoHum
HoHoHoHum Oct. 23 at 7:17 PM
$VERU is this going to ever come back? Or is this another case of slipping into the BK territory? I would be sad to see the latter happen but so many bios have disappeared into oblivion in the last 3 years.
0 · Reply
Eesnimi
Eesnimi Oct. 23 at 4:16 PM
$VERU All time low coming. Why not
0 · Reply
PennyConnection1
PennyConnection1 Oct. 23 at 2:55 PM
$VERU ladies and germs
0 · Reply
BioRich
BioRich Oct. 23 at 2:57 AM
$ALT $VERU I love it when my biggest stalker tries to bash me and my picks, only to fall on their face... yet again. Thanks @Turribull for trying to get cute with $VERU. Great company with near ZERO lean mass when added to Wegovy. $VERU is another $ALT killer. In a turn of beautiful fortune, $VERU proceeded to gain 4.7% from the time of your ill-advised bash attempt. Oh, and $ALT went down 2.5%. So that means your EE is 8.2% on your embarrassing post. *EE - Effective Embarrassment For those looking to make money and not just join bagholding misery cults... Follow/ Subscribe for more suggestions and perspective. Would love to hear yours. Let's make some money. Cheers!
1 · Reply
cray1965
cray1965 Oct. 22 at 9:40 PM
$VERU I get it — Veru’s history is ugly, no argument there. They’ve pivoted more than once and burned a lot of trust along the way. But calling it a scam is a bit much. And I don't work for Veru, and could just as easily call you a short seller. Enobosarm is real science with peer-reviewed data showing it builds muscle and improves function. The FDA literally gave them the green light for the next trial design (72 weeks, tirzepatide combo), and they just added Dr. Stefan Anker — one of the biggest names in muscle preservation — to the advisory board. That’s not what scam companies do. Yeah, management has made mistakes, but I’m buying the drug, not the drama. The molecule works — and if it does in the next trial what it’s already shown before, any big pharma would want it. That’s where the real value is. Believe what you want, but facts > feelings.
1 · Reply
Samspoti
Samspoti Oct. 22 at 11:10 AM
$VERU been a bit since Ive looked at this board. It’s as delusional as it’s ever been. This company went from treating cancer to covid to respiratory illnesses and now to weight loss. This is the biggest scam company and Im almost convinced the pumpers here are employed by veru. Sabi is a trash drug and its been around for a decade … of failures. Fireside chats, new board hires, small clinical trials…dont buy into this garbage stock! And certainly dont buy what these loyalists are pumping. I used to belong to a facebook group dedicated to this stock. Trust me, scam company.
1 · Reply
MrVeryNiceGuy
MrVeryNiceGuy Oct. 22 at 5:15 AM
$VERU Now that all the adjusted options expired they will likely get a call from the market maker allowing them to release the PR
0 · Reply
cray1965
cray1965 Oct. 21 at 8:33 PM
$VERU Anybody find it a coincidence that Lilly stopped their (more expensive) Bimagrumab T2D trial in June, right around the time of Veru's full phase 2 results, then officially terminated in Sept, a couple of days after Veru's eop2 meeting. Bimagrumab becomes basically obsolete(or lower priority) if you expect to have an oral muscle retention option.
1 · Reply
PennyConnection1
PennyConnection1 Oct. 21 at 2:57 PM
0 · Reply
mrkymrk
mrkymrk Oct. 21 at 1:54 PM
$VERU They also added another member to their scientific advisory board. Dr Stefan Anker from Germany.
2 · Reply
mrkymrk
mrkymrk Oct. 20 at 9:43 PM
$VERU the corporate presentation does not reference “pending additional funding” on their planned trial. A comment that was on all previous footnotes.
2 · Reply
mrkymrk
mrkymrk Oct. 20 at 1:54 PM
$VERU I hear your points cray but now listening to Steiner on his latest water tower podcast, he seems to indicate that they are running this small phase 2B in order to attract the big boys. Which implies that they have no current traction. Ie No NDA’s have been signed. Thoughts?
3 · Reply
cray1965
cray1965 Oct. 20 at 1:52 AM
$VERU (continued) 6. Veru(despite what they say) can’t(and shouldn’t) fund Phase2b and any big pharma that is interested wouldn’t want them to with such a small delta determining phase 3. 7.Roche/Regeron/Astrazenca /Phizer and others, desperate to get into the GLP gold rush. are largely boxed out by Novo and Lilly. Obtaining a muscle retention drug is a back door way of getting in. 8. Lilly has a small molecule GLP, and is increasing manufacturing capacity. Enobosarm is small molecule and could be easily manufactured in those same plants(and sent in the same package) 9. Enobosarm could be co-formulated with Lilly’s drug to make a single pill where you lose weight, and 100% of it is fat: the holy grail of weight loss pills. 10. For any major GLP player, owning enobosarm for defensive purposes is just as important as owning it for offensive purposes per the reasons mentioned above.
1 · Reply
cray1965
cray1965 Oct. 20 at 1:51 AM
$VERU Can someone stress test this for me, in case I’m off or missing something: 1. An oral muscle drug is a huge differentiator in the still early GLP gold rush, meaning whoever owns Enobosarm captures more new market share and steals market share from rivals. 2. Glps are moving to Oral. Enobosarm is the only oral muscle retention drug. Who would take an oral GLP and then an IV muscle retention drug. 3. Enobosarm could ultimately make more money for big pharma then even their GLPs because it has two uses(with GLP and maintenance) and can also be sold to all other GLPs for both of those uses, with no oral competition. 4. Veru is not acting(since final Phase 2 results) like a company that is actively promoting and shopping for funding as they run out of money. They are acting more like a company under NDA negotiations. 5. EOP2 changed the economics; bigger upside, less certainty, so it makes sense it would take longer to negotiate new terms even if they had been negotiating previously.
0 · Reply
QAZx666
QAZx666 Oct. 19 at 5:28 AM
$VERU Japan has a pandemic, what does that mean for Sabizabulin? https://www.nature.com/articles/d41586-025-03367-z
0 · Reply
QAZx666
QAZx666 Oct. 19 at 5:18 AM
$VERU Think Sabizabulin for those who did not get the right flu shots - https://www.nature.com/articles/d41586-025-03367-z
0 · Reply
cray1965
cray1965 Oct. 19 at 4:15 AM
$VERU Would Lilly really sit back and let Novo/Regeneron/Roche/Astrazeneca fund the new trial and potentially prove the incremental weight loss? That would be the biggest strategic blunder of the last 20 years, for a company that is supposed to be visionary. I don't get it.
0 · Reply